Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9

Human epidermal growth factor receptor 2 (HER-2)(+) breast cancer has a high recurrence rate and a poor prognosis, with drug resistance contributing to disease progression. The present study aimed to establish a SKBR3 cell line with type II insulin-like growth factor receptor (IGR-IIR) gene site int...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xinyu, Cao, Ru, Xiao, Haiyan, Cao, Zhongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586281/
https://www.ncbi.nlm.nih.gov/pubmed/33123265
http://dx.doi.org/10.3892/ol.2020.12216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586281/
https://www.ncbi.nlm.nih.gov/pubmed/33123265
http://dx.doi.org/10.3892/ol.2020.12216

Ejemplares similares